Market revenue in 2023 | USD 2,421.4 million |
Market revenue in 2030 | USD 3,895.3 million |
Growth rate | 7% (CAGR from 2023 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Pre-Clinical |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Discovery, Pre-Clinical, Clinical |
Key market players worldwide | Icon PLC, Charles River Laboratories International Inc, IQVIA Holdings Inc, GVK Biosciences, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, PAREXEL, Dassault Systemes SE, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, SGS AG, Worldwide Clinical Trials, Wuxi AppTec Co Ltd, Caidya |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract research organization market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 76.49% in 2023. Horizon Databook has segmented the Middle East & Africa healthcare contract research organization market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
Growth in the region can be attributed to the increased healthcare expenditure, rising demand for biosimilars & biologics therapies, R&D investments, and technological advancements. Several countries in the region are implementing global standards and collaborating with other global CROs to establish a presence in the market.
For instance, in September 2020, CTI Clinical Trial and Consulting Services acquired Clinart to expand its presence in the MEA. Outsourcing clinical trials to a local CRO with regional language proficiency and local regulatory expertise can be advantageous for companies looking to increase their share in the MEA.
Despite aggressive investment in new technologies by companies and governments acting as early adopters, AI adoption has been slower in certain areas outside the Gulf economies.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa healthcare contract research organization market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa healthcare contract research organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account